{"schema_version":"1","generated_at":"2026-10-28T16:42:50.094Z","data_as_of":null,"url":"https://www.findmykol.com/kol/steven-powell-sd","json_url":"https://www.findmykol.com/kol/steven-powell-sd/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"steven-powell-sd","name":"Steven Powell","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Sioux Falls","state":"SD","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1548454291"},"summary":"Steven Powell is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":3,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04093557","title":"Improving Outpatient Colonoscopy Bowel Prep With the Orton Score","phase":"NA","status":"WITHDRAWN","role":"Overall official","sponsor":"University of Virginia","source_url":"https://clinicaltrials.gov/study/NCT04093557","trial_url":"https://www.findmykol.com/trial/NCT04093557"},{"nct":"NCT02586207","title":"Pembrolizumab in Combination With CRT for LA-SCCHN","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Sanford Health","source_url":"https://clinicaltrials.gov/study/NCT02586207","trial_url":"https://www.findmykol.com/trial/NCT02586207"},{"nct":"NCT02416518","title":"Genetic Exploration of the Molecular Basis of Malignancy in Adults","status":"COMPLETED","role":"Overall official","sponsor":"Sanford Health","source_url":"https://clinicaltrials.gov/study/NCT02416518","trial_url":"https://www.findmykol.com/trial/NCT02416518"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2023,"amount_usd":645,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548454291"},{"payer":"Merck Sharp & Dohme LLC","program_year":2023,"amount_usd":19.81,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548454291"},{"payer":"Alkermes, Inc.","program_year":2022,"amount_usd":1460,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548454291"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1548454291","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":34.9,"classes_total":5,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":17.8,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":5.9,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":16.2,"classes_total":2,"classes":[{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":9,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":null},{"class":"Phenothiazine","setting":"prescribed","share_pct":7.2,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":19}]},{"area":"Sensory organs","share_pct":11.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":11.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":4.8,"facility_pct":95.2},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2016,"last":2020},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P20GM103548","title":"The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy","fiscal_year":2020,"amount_usd":"288946","organization":"SANFORD RESEARCH/USD","source_url":"https://reporter.nih.gov/quickSearch/P20GM103548"},{"project":"P20GM103548","title":"The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy","fiscal_year":2019,"amount_usd":"289592","organization":"SANFORD RESEARCH/USD","source_url":"https://reporter.nih.gov/quickSearch/P20GM103548"},{"project":"P20GM103548","title":"The Impact of PD-1 Inhibition on Immune-Response to Chemoradiotherapy","fiscal_year":2018,"amount_usd":"289754","organization":"SANFORD RESEARCH/USD","source_url":"https://reporter.nih.gov/quickSearch/P20GM103548"}],"source":"grants"},"contact":{"address_1":"1309 W 17TH ST STE 101","city":"Sioux Falls","state":"SD","zip":"571048805","phone":"605-328-8000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1548454291","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":1,"funding":2}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-04-17","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}